IFFIm receives eighth consecutive A+ rating from UK FCDO
- Press Releases
- IFFIm receives eighth consecutive A+ rating from UK FCDO
IFFIm receives eighth consecutive A+ rating from UK FCDO
20 November 2026
The UK Foreign, Commonwealth & Development Office's 2025 Annual Review confirms an A+ rating for IFFIm for the eighth year running.
The UK Foreign, Commonwealth & Development Office's 2025 Annual Review confirms an A+ rating for IFFIm for the eighth year running.
Consistency is the strongest evidence that a financing mechanism works. IFFIm is delighted to be a model of consistency, with its eighth consecutive A+ rating from the UK Foreign, Commonwealth & Development Office's (FCDO) 2025 Annual Review.
As a global financing platform, IFFIm allows Gavi, the Vaccine Alliance to frontload resources or draw down funds over time, enabling Gavi to invest in immunisation programmes when funds will have the greatest impact. In parallel, IFFIm’s steady funding stream strengthens Gavi’s ability to shape vaccine markets while also providing it with access to fast, reliable surge financing in case of emergencies. With the World Bank serving as the facility's treasury Manager since inception, IFFIm has proven to be an effective model for donors looking to accelerate the life-saving returns on their contributions.
Why the rating matters
The UK is IFFIm's founding and largest sovereign donor, and it assesses IFFIm every year as an efficient and effective financial instrument. An eighth consecutive A+ rating shows that the IFFIm’s model is consistent and resilient, and signals to donors worldwide that the UK believes IFFIm performs highly in supporting global immunisation outcomes at scale.
That consistency builds trust. By turning long-term donor pledges into funding that is available immediately, IFFIm helps Gavi to plan, commit and negotiate with confidence; not just as a financial tool, but as a trusted partner. As global health challenges become more complex, it is more vital than ever for Gavi to be able to deliver at speed, and to ensure strategic impact every time, without fail.
Looking ahead
Twenty years after its founding, IFFIm embarks on Gavi’s new five-year strategy – Phase 6 – to materialise its vision: Leaving no one behind with immunisation. That means saving lives and protecting people’s health by increasing the equitable and sustainable use of vaccines worldwide. Donors play a crucial role in making this happen.
As well as assessing recent performance, the FCDO review also looks ahead. Its recommendations equip IFFIm with valuable tools to deepen and broaden its relationships with the donors that will help make the vision of Gavi 6.0 a reality.
“An eighth A+ rating in FCDO’s annual review, as we celebrate IFFIm’s 20th anniversary, is a significant recognition of the strength and enduring relevance of IFFIm’s innovative financing model,” said Georgina Baker, Chair of the IFFIm Board. “Over the past two decades, IFFIm has demonstrated how bringing financing forward can help deliver timely and meaningful impact for global immunisation. As we look ahead, this recognition reinforces the important role innovative finance can continue to play in responding to global health needs.”
Rachel Turner, IFFIm Board Member, added: “Having been there at the beginning of IFFIm, it is remarkable to look back and see how an ambitious idea has evolved into a proven approach that has stood the test of time. Twenty years later, receiving an eighth A+ rating in FCDO’s annual review is an important milestone and a moment to be proud of. It reflects what IFFIm has achieved over two decades and, importantly, the dedication and collaboration of everyone who has played a part in its success along the way.”
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.